Long‐term results of a randomized controlled trial comparing neoadjuvant Adriamycin, cisplatin, and 5‐fluorouracil vs docetaxel, cisplatin, and 5‐fluorouracil followed by surgery for esophageal cancer (OGSG1003)

AIM: The aim is to report the long‐term outcomes of preoperative cisplatin and fluorouracil plus docetaxel (DCF) vs Adriamycin (ACF) for resectable esophageal squamous cell carcinoma (ESCC). Previously, this trial showed that DCF is associated with prolonged recurrence‐free survival (RFS). METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugimura, Keijiro, Yamasaki, Makoto, Yasuda, Takushi, Yano, Masahiko, Hirao, Motohiro, Fujitani, Kazumasa, Kimura, Yutaka, Miyata, Hiroshi, Motoori, Masaaki, Takeno, Atsushi, Shiraishi, Osamu, Makino, Tomoki, Kii, Takayuki, Tanaka, Koji, Satoh, Taro, Mori, Masaki, Doki, Yuichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832970/
https://www.ncbi.nlm.nih.gov/pubmed/33532683
http://dx.doi.org/10.1002/ags3.12388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832970/
https://www.ncbi.nlm.nih.gov/pubmed/33532683
http://dx.doi.org/10.1002/ags3.12388

Ejemplares similares